Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

WU Menghang ^1,2 ,  TANG Li ^1,2 , REN Qiuping ^1,2 , YANG Jiayin ¹ , WEN Tianfu ¹ , WU Hong ¹ , WANG Wentao ¹ , LI Bo ¹ , LUO Yanli ^1,2 , WAN Juan ^1,2 , YU Jingya ^1,2 , WU Tao ¹

1. Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, R. P. China;
2. West China Hospital of Sichuan University / West China College of Nursing, Chengdu 610041, R. P. China;

Corresponding?author：

TANG Li, Email: 776716926@qq.com

Keywords：

novel coronavirus; cardiac death organ donation; liver transplantation; risk prevention and control

DOI：

10.7507/1007-9424.202003057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To construct a rapid screening tool for the donor of heart dead organ donation (donation after circulatory death, DCD) in the background of novel coronavirus (SARS-CoV-2) infection.Methods Based on literature analysis and core group discussion, two rounds of expert consultation were carried out by Delphi method to establish dimension and index.Results The screening tool included 3 dimensions, including epidemiological history, hospital exposure history, and clinical manifestations, with 15 entries. The mean of the two rounds of expert authority coefficient was 0.757 and 0.768, and the effective recovery rate of the expert consultation questionnaire was 88% and 100%, respectively. The second round dimension and index coordination coefficients was 0.417 and 0.319, respectively. The content validity of the questionnaire was 0.91.Conclusions The DCD liver transplant donor's new rapid screening tool for SARS-CoV-2 infection is scientific and reliable. During the epidemic period, the DCD liver transplant donor risk screening tool is of great significance to the prevention and control of liver transplantation risk.

Citation： WU Menghang, TANG Li, REN Qiuping, YANG Jiayin, WEN Tianfu, WU Hong, WANG Wentao, LI Bo, LUO Yanli, WAN Juan, YU Jingya, WU Tao. Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(5): 521-526. doi: 10.7507/1007-9424.202003057 Copy

1.	央視新聞客戶端. 肺炎疫情 24 小時: 黨中央成立應對疫情工作領導小組 30 個省市自治區已啟動一級公共衛生事件響應. 2020-01-25. http://m.news.cctv.com/2020/01/25/ARTIVdXxhUzobSvozuL6cQ44200125.shtml.
2.	Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
3.	Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med, 2020, 46(2): 357-360.
4.	McNeill G, Bryden D. Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation, 2013, 84(12): 1652-1667.
5.	沈恬, 莊莉, 孫曉東, 等. 中國肝移植受者代謝病管理專家共識(2019版). 中華移植雜志(電子版), 2019, 13(3): 187-194.
6.	新型冠狀病毒感染的肺炎診療方案(試行第五版). 2020-02-21. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440/files/7260301a393845fc87fcf6dd52965ecb.pdf.
7.	于長禾, 孫亞男, 何麗云, 等. 量表研制及測量屬性評價標準的比較研究. 世界科學技術-中醫藥現代化, 2015, 17(6): 1127-1135.
8.	王春枝, 斯琴. 德爾菲法中的數據統計處理方法及其應用研究. 內蒙古財經學院學報(綜合版), 2011, 9(4): 92-96.
9.	伍琳, 孫艷杰. 德爾菲法簡介及在護理學中的應用現狀. 護理研究, 2015, 29(29): 3599-3601.
10.	Kumar D, Tellier R, Draker R, et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant, 2003, 3(8): 977-981.
11.	謝淑云, 曾光, 雷杰, 等. 一起傳染性非典型肺炎爆發的“超級傳播者”和傳播鏈分析. 中華流行病學雜志, 2003, 24(6): 449-453.
12.	白浪, 王銘, 唐小瓊, 等. 對新型冠狀病毒肺炎診療中的熱點問題的思考. 華西醫學, 2020, 35(2): 125-131.
13.	呂濤, 楊家印, 嚴律南, 等. 新型冠狀病毒性肺炎疫情時期器官移植調整策略及體會. 中國普外基礎與臨床雜志, 2020, 27(3): 261-264.
14.	Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020, 382(13): 1199-1207.
15.	Kumar D, Manuel O, Natori Y, et al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant, 2020 Mar 23. [Epub ahead of print].
16.	新型冠狀病毒肺炎診療方案(試行第六版). 2020-02-19. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
17.	陳燕雅, 齊蒙蒙, 李澤楷. 護理本科生職業相關社會支持量表的編制及信效度檢驗. 護理管理雜志, 2017, 17(10): 723-726.
18.	史靜琤, 莫顯昆, 孫振球. 量表編制中內容效度指數的應用. 中南大學學報(醫學版), 2012, 37(2): 49-52.

1. 央視新聞客戶端. 肺炎疫情 24 小時: 黨中央成立應對疫情工作領導小組 30 個省市自治區已啟動一級公共衛生事件響應. 2020-01-25. http://m.news.cctv.com/2020/01/25/ARTIVdXxhUzobSvozuL6cQ44200125.shtml.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
3. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med, 2020, 46(2): 357-360.
4. McNeill G, Bryden D. Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation, 2013, 84(12): 1652-1667.
5. 沈恬, 莊莉, 孫曉東, 等. 中國肝移植受者代謝病管理專家共識(2019版). 中華移植雜志(電子版), 2019, 13(3): 187-194.
6. 新型冠狀病毒感染的肺炎診療方案(試行第五版). 2020-02-21. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440/files/7260301a393845fc87fcf6dd52965ecb.pdf.
7. 于長禾, 孫亞男, 何麗云, 等. 量表研制及測量屬性評價標準的比較研究. 世界科學技術-中醫藥現代化, 2015, 17(6): 1127-1135.
8. 王春枝, 斯琴. 德爾菲法中的數據統計處理方法及其應用研究. 內蒙古財經學院學報(綜合版), 2011, 9(4): 92-96.
9. 伍琳, 孫艷杰. 德爾菲法簡介及在護理學中的應用現狀. 護理研究, 2015, 29(29): 3599-3601.
10. Kumar D, Tellier R, Draker R, et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant, 2003, 3(8): 977-981.
11. 謝淑云, 曾光, 雷杰, 等. 一起傳染性非典型肺炎爆發的“超級傳播者”和傳播鏈分析. 中華流行病學雜志, 2003, 24(6): 449-453.
12. 白浪, 王銘, 唐小瓊, 等. 對新型冠狀病毒肺炎診療中的熱點問題的思考. 華西醫學, 2020, 35(2): 125-131.
13. 呂濤, 楊家印, 嚴律南, 等. 新型冠狀病毒性肺炎疫情時期器官移植調整策略及體會. 中國普外基礎與臨床雜志, 2020, 27(3): 261-264.
14. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020, 382(13): 1199-1207.
15. Kumar D, Manuel O, Natori Y, et al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant, 2020 Mar 23. [Epub ahead of print].
16. 新型冠狀病毒肺炎診療方案(試行第六版). 2020-02-19. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
17. 陳燕雅, 齊蒙蒙, 李澤楷. 護理本科生職業相關社會支持量表的編制及信效度檢驗. 護理管理雜志, 2017, 17(10): 723-726.
18. 史靜琤, 莫顯昆, 孫振球. 量表編制中內容效度指數的應用. 中南大學學報(醫學版), 2012, 37(2): 49-52.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content